-
MJFF Awardee to Study Drug with Potential to Treat Dyskinesia
October 24, 2012
… AVP-923 is also currently in development to treat multiple sclerosis. Nate Herpich …
-
Albert J. Hunt, Jr., PhD, MBA
… Operations at Cogentis Therapeutics, Inc., Dr. Hunt has led multiple preclinical studies through industry and academic …
-
Dominick Auci, PhD
… at Brooklyn, scientific program manager at the National Multiple Sclerosis Society, and manager of Biomedical …
-
Suresh Dheerendra, MS
… Suresh was a Clinical Program Director at Genentech leading multiple programs from entry into the clinic to late-stage …
-
Development of Novel Brain-penetrant Inflammasome Inhibitors as Potential Therapeutics for Parkinson’s Disease
… Study Rationale: The immune system displays an aberrant pattern of activity in the central nervous system of people with Parkinson’s disease (PD); this pattern … Although short-term activation of the immune system can be beneficial in fighting infections or healing …
-
Xiaolu Yang, PhD
… and his lab discovered a new protein quality control (PQC) system in animal cells. This system is highly effective in suppressing protein misfolding … and is mechanistically distinct from canonical PQC systems. A main research focus of his lab now is to …